These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Decrease of antigastric autoantibodies in Helicobacter pylori gastritis after cure of infection. Faller G; Winter M; Steininger H; Lehn N; Meining A; Bayerdörffer E; Kirchner T Pathol Res Pract; 1999; 195(4):243-6. PubMed ID: 10337662 [TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori detection and genotyping in gastric biopsy specimens from Chennai patients (India). Udhayakumar G; Senthilkumar C; Jayanthi V; Devaraj N; Devaraj H Can J Microbiol; 2009 Feb; 55(2):126-32. PubMed ID: 19295644 [TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection with parietal cell antibodies in children and adolescents with insulin dependent diabetes mellitus. Barrio R; Roldán MB; Alonso M; Cantón R; Camarero C J Pediatr Endocrinol Metab; 1997; 10(5):511-6. PubMed ID: 9401908 [TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection and peptic ulcer disease in Uzbekistan. Abdiev S; Ahn KS; Rahimov B; Bahramov S; Malikov YR; Khadjibaev AM; Kurbanov F; Hamajima N Helicobacter; 2008 Aug; 13(4):304-5. PubMed ID: 18665941 [No Abstract] [Full Text] [Related]
15. [Helicobacter pylori and erosive lesions of the gastric mucosa in cirrhosis]. Mosca S; Balzano A; Rocco VP; Di Blasi A; Piccirillo MM; Gigliotti T Gastroenterol Clin Biol; 1991; 15(12):983-4. PubMed ID: 1783258 [No Abstract] [Full Text] [Related]
16. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases. Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700 [TBL] [Abstract][Full Text] [Related]
17. [Immunologic study of chronic gastritis]. Sugiyama T; Yachi A Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1390-3. PubMed ID: 8245632 [No Abstract] [Full Text] [Related]
18. Presence of thrombin-activatable fibrinolysis inhibitor in Helicobacter pylori-associated gastroduodenal disease. Ikeda A; Gabazza EC; Morser J; Imoto I; Kuroda M; D'Alessandro-Gabazza CN; Hara K; Ruiz DB; Bernabe PG; Katsurahara M; Toda M; Kobayashi Y; Yano Y; Sumida Y; Suzuki K; Taguchi O; Takei Y Helicobacter; 2009 Apr; 14(2):147-55. PubMed ID: 19298343 [TBL] [Abstract][Full Text] [Related]